Literature DB >> 10395751

Methionine S-oxidation in human and rabbit liver microsomes: evidence for a high-affinity methionine S-oxidase activity that is distinct from flavin-containing monooxygenase 3.

S L Ripp1, K Itagaki, R M Philpot, A A Elfarra.   

Abstract

Methionine has previously been shown to be S-oxidized by flavin-containing monooxygenase (FMO) forms 1, 2, and 3. The most efficient catalyst was FMO3, which has a Km value for methionine S-oxidation of approximately 4 mM, and exhibits high selectivity for formation of the d-diastereoisomer of methionine sulfoxide. The current studies provide evidence for an additional methionine S-oxidase activity in liver microsomes. Human and rabbit liver microsomes exhibited a biphasic response to methionine at concentrations ranging from 0.05 to 10 mM, as indicated by both Eadie-Hofstee plots and nonlinear regression. The low-affinity component of the biphasic response had Km values of approximately 3 and 5 mM for humans and rabbits, respectively, as well as high diastereoselectivity for methionine sulfoxide formation. The low-affinity activity in rabbit liver microsomes was inhibited by methimazole, S-allyl-l-cysteine, and by mild heat treatment, suggesting the activity is FMO3. The high-affinity component of the biphasic response had Km values of approximately 0.07 and 0.04 mM for humans and rabbits, respectively, as well as lower diastereoselectivity for methionine sulfoxide formation. Further characterization of the high-affinity activity in rabbit liver microsomes indicated lack of involvement of cytochrome P450s or reactive oxygen species. The high-affinity activity was inhibited 25% by potassium cyanide and greater than 50% by methimazole and S-allyl-l-cysteine. Mild heat treatment produced 85% inhibition of the low-affinity activity, but only 30% inhibition of the high-affinity activity. Both high- and low-affinity activities were decreased by 85% in flavin-depleted microsomes. Because these results suggested the additional S-oxidase activity has characteristics of an FMO, recombinant human FMO4 was evaluated as a potential catalyst of this activity. Recombinant FMO4 catalyzed S-oxidation of both methionine and S-allyl-l-cysteine, with similar diastereoselectivity to the high-affinity microsomal S-oxidase; however, the Km values for both reactions appeared to be greater than 10 mM. In summary, these studies provide evidence for two microsomal methionine S-oxidase activities. FMO3 is the predominant catalyst at millimolar concentrations of methionine. However, at micromolar methionine concentrations, there is an additional S-oxidase activity that is distinct from FMO3. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395751     DOI: 10.1006/abbi.1999.1247

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

Review 1.  The biological significance of methionine sulfoxide stereochemistry.

Authors:  Byung Cheon Lee; Vadim N Gladyshev
Journal:  Free Radic Biol Med       Date:  2010-11-11       Impact factor: 7.376

Review 2.  The biochemical and toxicological significance of hypermethionemia: new insights and clinical relevance.

Authors:  Joseph T Dever; Adnan A Elfarra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-09-28       Impact factor: 4.481

3.  Oxidative metabolism of seleno-L-methionine to L-methionine selenoxide by flavin-containing monooxygenases.

Authors:  Renee J Krause; Steven C Glocke; Anna Rita Sicuri; Sharon L Ripp; Adnan A Elfarra
Journal:  Chem Res Toxicol       Date:  2006-12       Impact factor: 3.739

4.  Ancestral-sequence reconstruction unveils the structural basis of function in mammalian FMOs.

Authors:  Callum R Nicoll; Gautier Bailleul; Filippo Fiorentini; María Laura Mascotti; Marco W Fraaije; Andrea Mattevi
Journal:  Nat Struct Mol Biol       Date:  2019-12-23       Impact factor: 15.369

Review 5.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.

Authors:  Sharon K Krueger; David E Williams
Journal:  Pharmacol Ther       Date:  2005-06       Impact factor: 12.310

Review 6.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

7.  Gender differences in methionine accumulation and metabolism in freshly isolated mouse hepatocytes: potential roles in toxicity.

Authors:  Joseph T Dever; Adnan A Elfarra
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-21       Impact factor: 4.219

8.  Purification and characterization of flavin-containing monooxygenase isoform 3 from rat kidney microsomes.

Authors:  Rachel M Novick; Adnan A Elfarra
Journal:  Drug Metab Dispos       Date:  2008-09-05       Impact factor: 3.922

9.  Differential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomes.

Authors:  Rachel M Novick; Ann M Mitzey; Mark S Brownfield; Adnan A Elfarra
Journal:  J Pharmacol Exp Ther       Date:  2009-03-23       Impact factor: 4.030

10.  Isoform distinct time-, dose-, and castration-dependent alterations in flavin-containing monooxygenase expression in mouse liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.

Authors:  Rachel M Novick; Chad M Vezina; Adnan A Elfarra
Journal:  Biochem Pharmacol       Date:  2009-12-28       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.